|
|
CTD6639
|
ACRIPTEGA
|
LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE AND DOLUTEGRAVIR
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7980/16504
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7079/13566
|
DOLUTEGRAVIR 50MG , LAMIVUDINE 300MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS
|
DOLUTEGRAVIR SODIUM,LAMIVUDINE USP TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD7411
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7411/14564
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG TABLETS
|
EACH FILM COATED TABLET CONTAINS 52.6 MG OF DOLUTEGRAVIR SODIUM EQUIVALENT TO 50 MG OF DOLUTEGRAVIR, 300 MG OF LAMIVUDINE USP AND 300 MG OF TENOFOVIR DISOPROXIL FUMARATE (EQUIVALENT TO 245 MG OF TENOFOVIR DISOPROXIL).
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2021/CTD8639/19826
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50/300/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
EVKA CONSULTZ LTD
|
Registered
|
Details →
|
|
|
H2021/CTD8566/18403
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
TIBA HEALTHCARE LIMITED
|
Registered
|
Details →
|
|
|
H2025/CTD11527/23967
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG / 300 MG / 300 MG TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DISOPROXIL FUMARATE
|
MICRO LABS (EA) LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7486/14555
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2024/CTD11571/23976
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG, 300 MG AND 300 MG
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
NAIROBI ENTERPRISES LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9938/22681
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/ 300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD7966/16130
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50MG, 300MG AND 300MG
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50MG, 300MG AND 300MG.
|
NAIROBI ENTERPRISES LTD
|
Registered
|
Details →
|
|
|
H2017/CTD4812/195
|
DOLUTEGRAVIR, LAMIVUDINE TENOFOVIR DISOPROXIL FUMARATE
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
SIMBA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2024/CTD11510/25491
|
SIROPIL
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS (50/300/300 MG)
|
LAZOR PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
H2019/CTD7411/14564/R1
|
Dolutegravir Lamivudine and Tenofovir Disoproxil…
|
Each film coated tablet contains 52.6 mg of…
|
M/s. Hetero Labs Limited
|
Retained
|
Details →
|
|
|
H2022/CTD10906/21966
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG/300 MG/25 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
CTD6648
|
TEFODAY TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE EQ TO TENOFAVIR
|
ALFAJIRI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD6648/18093ER
|
TEFODAY TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE EQ TO TENOFAVIR
|
ALFAJIRI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2020/CTD8181/17179
|
TENOFOVIR DISOPROXIL FUMARATE/LAMIVUDINE/DOLUTEGRAVIR
|
TENOFOVIR DISOPROXIL FUMARATE/LAMIVUDUNE/DOLUTEGRAVIR
|
UNIVERSAL CORPORATION LTD
|
Registered
|
Details →
|
|
|
H2021/CTD7784/14888
|
VIROPIL
|
LAMIVUDINE USP+TENOFOVIR DISOPROXIL FUMARATE+DOLUTEGRAVIR SODIUM
|
LAZOR PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|